Here's what workplaces young professionals are the most happy. Photo via Getty Images

Ten businesses in the Greater Houston area are clocking in among the country's best employers for millennials, according to a new report.

The Best Workplaces for Millennials list is published annually by Fortune magazine and compiled by Great Place to Work, a company that focuses on improving workplace culture.

Looking at the 10 Houston-area employers, mega developer David Weekley homes takes the top spot. The company appears at No. 12 on the list of large employers.

"It's an honor to once again be recognized as a top company for working millennials," said Robert Hefner, David Weekly vice president of human resources, in a statement. "We are very proud to offer a rewarding workplace culture as well as competitive benefits and amazing perks to draw this group of young talent to our award-winning team."

In that survey, 97 percent of staffers called David Weekley Homes a great place to work. The home builder previously ranked at number 26 on the 2020 list.

Joining David Weekly on the list are these large, mid-size, and small Houston-area companies:

Large employers:

  • Camden Property Trust, No. 32
  • Hilcorp, No. 37
  • Cornerstone Home Lending, No. 38
  • Transwestern, No. 65
  • Hewlett Packard Enterprise, No. 95

Small and mid-sized employers:

  • Continued, No. 33
  • Venterra Realty, No. 49
  • Republic State Mortgage, No. 90
  • E.A.G. Services, No. 91

Here's how employers in Texas' other major metro areas fared.

Dallas

  • Plano-based Granite: No. 6
  • Addison-based Credera, No. 36
  • Dallas-based Pariveda Solutions, No. 76
  • Dallas-based Embark, No. 97
  • Dallas-based PrimeLending lands at No. 29
  • Dallas-based Ryan LLC at No. 35.

Austin

Large employers:

  • Round Rock-based Dell Technologies, No. 75

Small and mid-sized employers:

  • Austin-based OJO Labs, No. 51
  • Austin-based SailPoint, No. 60
  • Austin-based Sedera Health, No. 69
  • Austin-based The Zebra, No. 86

San Antonio

Large employers:

  • San Antonio-based NuStar Energy, No. 91
  • San Antonio-based USAA, No. 98

"The Best Workplaces for Millennials treat their employees like people, not just employees," says Michael Bush, CEO of Great Place to Work. "These companies foster caring and respect for one another, at every level of the organization. The result is millennial employees who say they look forward to coming to work and — as our research says — are 50 times more likely to stay a long time."

------

This article originally ran on CultureMap.

Carrie Colbert saw an opportunity is funding female-founded companies, and she's taking it. Photo courtesy of Curate Capital

Houston investor goes all in on funding female founders

HOUSTON INNOVATORS PODCAST EPISODE 81

Carrie Colbert wasn't planning on becoming a venture capital investor — it just happened organically.

"This has been kind of a backwards process. Our fund was driven by demand," Colbert, founder and general partner of Houston-based Curate Capital, says on this week's episode of the Houston Innovators Podcast. "We were getting such good deal flow in terms of quantity and quality."

Colbert says she originally carved out a practical career and worked her way up the corporate ladder within the energy industry — first at Anadarko Petroleum and then at Hilcorp Energy Co. — for almost 20 years. On the side, she was also establishing herself as a prominent content creator specializing in all things colorful on her blog and Instagram.

It was through the network she created that she started learning about up-and-coming businesses that she wanted to get involved in — first as an angel investor for a few years and now through her VC.

"Instagram turned out to be one of the best networking tools for me," Colbert says. "You can connect with people wherever they are and wherever you are."

A prime example of this interaction was Jordan Jones, founder and CEO of Austin-based consumer goods company, Packed Party. Jones suggested meeting up with Colbert, and the two hit it off. Down the road when it came time to fundraise, Colbert became Jones' first outside investor.

"I've never had to search for deals," Colbert says. "I connect with them on social media or, in pre-pandemic days, I meet them at creative conferences."

Now, under her Curate Capital, Colbert is raising an initial $10 million fund — and she's already committed about 40 percent of that into companies across industries — consumer packaged goods, fintech, health tech, and more.

"We are not industry specific," Colbert says. "Rather, where I have found our sweet spot to be is businesses by women, for women... That's where I think I can provide the most value."

Female founders continue to be funded less than their male counterparts, and Crunchbase reported that last year the discrepancy increased drastically. Colbert recognizes this need and carved out her niche accordingly.

"Women control so much of the spending, and yet are getting so few of the VC dollars. We really see that as an opportunity. It's not a problem we're trying to fix necessarily — we certainly can't rectify it on our own," Colbert says.

Colbert expects her first fund's initial close around July, and she also plans on announcing new investments in the next few weeks. She's also working on bringing on new limited partners and will soon be launching a crowdfunding opportunity to get more women in her network involved.

Colbert shares more about Curate Capital and her advice for her fellow female entrepreneurs on the episode. Listen to the full interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

7+ can't-miss Houston business and innovation events in June 2026

where to be

Editor's note: The FIFA World Cup comes to Houston this month, joined by major energy conferences and a lineup of fan-favorite, recurring events. Here’s what not to miss and how to register. Please note: this article may be updated to add more events.


June 1-4 — CLEANPOWER 2026 Conference and Exhibition

CLEANPOWER unites policymakers, experts, and corporate leaders to solve the challenges that none can solve alone. This must-attend, four-day conference is packed with cutting-edge discussions about wind, solar, storage, and transmission; dealmaking; networking; and fun.

This event begins June 1 at the George R. Brown Convention Center. Register here.

June 2 — Humans of Healthcare

Houston Methodist Center for Innovation will present its quarterly speaker series, Humans of Healthcare. The series will feature a panel of experts who will share about their career paths and discuss the nuances of the health care industry. This month's session will focus on today’s nursing landscape, the industry’s expectations of nurses and what career paths are possible in the field.

The event is Tuesday, June 2, from 5-6:30 p.m. at the Ion. Register here.

June 9 — Greentown Go Make Kickoff

Head to the Ion to celebrate the Greentown Go Make 2026 cohort. The open-innovation program with Shell Catalysts & Technologies and Technip Energies focuses on catalytic solutions for industrial decarbonization and the energy transition. Hear pitches from the founders and network with a select group of startups while enjoying food and drink.

This event is Tuesday, June 9, from 5:30-8 p.m. Register here.

June 9-10 — Texas Brain Economy Summit

The Center for Houston’s Future and UTMB are bringing the Texas Brain Economy Summit back to Houston this summer to continue to position the region as a global leader in brain health. Expect to hear from leaders of global institutions, including the World Economic Forum, U.S. Chamber of Commerce, McKinsey Health Institute, Global Brain Economy Initiative, Davos Alzheimer’s Collaborative, Business Collaborative for Brain Health (UsAgainstAlzheimer’s), Rice University, Memorial Hermann, MD Anderson and many others. Read InnovationMap's full preview of the event here.

This event begins Tuesday, June 9. Purchase tickets here.

June 10 — MIT Future of Healthcare Technology Forum

The MIT Club of South Texas will host an in-person forum to explore how innovation, government and policy are changing the healthcare industry. The event will feature MIT alumni and Houston healthcare leaders, including Dr. Tim Boone, dean of the Texas A&M School of Engineering Medicine; Cynthia Reinhart-King, chair of bioengineering at Rice University; Dr. Tony Lin, CEO and chairman emeritus of Kelsey-Seybold Clinic; and others.

This event is Wednesday, June 10, from 5:15-8:30 p.m. at the TAMU EnMed Building. Register here.

June 11 — Goals & Gigawatts: Houston Energy & Climate Week The Power of & Kickoff Party

Come watch the Mexico City FIFA opening match while celebrating energy and innovation at the Goals & Gigawatts Kickoff Party. The event will feature food, drinks, and a showcase on Houston Energy & Climate Week. Learn what to expect and how to get involved in HECW before closing the night with a DJ and karaoke.

This event is Thursday, June 11, from 1:30-6:30 p.m. Find more information here.

June 16-17 — Energy Projects Conference & Expo

The Energy Projects Conference & Expo (EPC Show) is the largest event in North America for professionals working at the heart of major energy projects. The essential event for engineering, construction, commissioning, operations and maintenance across multiple energy sectors brings together five leading conferences under one roof. Conference subjects span LNG exporting, hydrogen and ammonia, midstream, petrochem and refining, and sustainable aviation fuels.

This event begins June 16 at George R. Brown Convention Center. Register here.

June 25 – NASA Tech Talk

Every fourth Thursday of the month, NASA experts, including longtime engineer Montgomery Goforth, present on technology development challenges NASA’s Johnson Space Center and the larger aerospace community are facing, and how they can be leveraged by Houston’s innovation community. Stick around after for drinks and networking at Second Draught.

This event is Thursday, June 25, from 6-7 p.m. at the Ion. Register here.

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”